News Snapshot:
'Countdown to catastrophe' in Yemen as U.N. warns of famine - again By Anthony Boadle © Reuters/THOMAS PETER FILE PHOTO: Media tour at Chinese vaccine maker Sinovac Biotech in Beijing BRASILIA (Reuters) - Brazil health regulator Anvisa on Wednesday allowed resumption of late-stage clinical trials for China's Sinovac COVID-19 vaccine, which had been suspended due to the death of a study subject that was registered in Sao Paulo as a suicide. Brazilian medical institute Butantan said in a statement it would restart trials later on Wednesday. Brazil's President Jair Bolsonaro, a longtime China skeptic who has baselessly dismissed the Sinovac...
